Trials / Conditions / IDH1 Gene Mutation
IDH1 Gene Mutation
5 registered clinical trials studyying IDH1 Gene Mutation — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia NCT07007949 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Active Not Recruiting | AG-120 in People With IDH1 Mutant Chondrosarcoma NCT04278781 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas NCT03749187 | University of California, San Francisco | Phase 1 |
| Terminated | Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis NCT03303950 | University of Utah | Phase 2 |
| Unknown | Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia NCT04369287 | Istituto Clinico Humanitas | — |